PW
GILD icon

Price Wealth’s Gilead Sciences GILD Stock Holding History

Price Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$32K Buy
514
+351
+215% +$24.3K 0.01% 154
2020
Q2 		$13K Hold
163
– – ﹤0.01% 148
2020
Q1 		$12K Buy
163
+143
+715% +$9.88K ﹤0.01% 146
2019
Q4 		$1K Buy
+20
New +$1.3K ﹤0.01% 303
2018
Q3 		– Sell
-391
Closed -$27K – 264
2018
Q2 		$27K Buy
391
+248
+173% +$17.5K 0.01% 164
2018
Q1 		$11K Sell
143
-143
-50% -$11.4K 0.01% 153
2017
Q4 		$20K Buy
+286
New +$21.7K 0.01% 116

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Price Wealth's GILD Position: Q3 2020 in Review

Price Wealth increased its Gilead Sciences (GILD) stake by 215% in Q3 2020, buying an estimated $24.3K and bringing the position to 514 shares worth $32K. The position accounts for 0.01% of the portfolio, ranked #154.

Price Wealth first reported a position in GILD in Q4 2017 and has held it in 7 quarters since. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Price Wealth held 514 shares of Gilead Sciences worth $32K as of Q3 2020.
  • Price Wealth bought 351 Gilead Sciences shares in Q3 2020, an estimated $24.3K.
  • Gilead Sciences made up 0.01% of Price Wealth's portfolio in Q3 2020, its #154 holding.
  • Price Wealth first reported a position in Gilead Sciences in Q4 2017 and has held it in 7 quarters since.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Price Wealth's 13F filing for Q3 2020, filed 22 Oct 2020.